Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stem Cell Infusion”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT03857841
What this trial is testing

A Safety Study of IV Stem Cell-derived Extracellular Vesicles (UNEX-42) in Preterm Neonates at High Risk for BPD

Who this might be right for
Bronchopulmonary Dysplasia
United Therapeutics 3
Early research (Phase 1)WithdrawnNCT03825783
What this trial is testing

A Gene Therapy Trial to Evaluate the Safety and Efficacy of RP-L201 in Subjects With Leukocyte Adhesion Deficiency-I

Who this might be right for
Leukocyte Adhesion Defect - Type I
Rocket Pharmaceuticals Inc.
Large-scale testing (Phase 3)Looking for participantsNCT07047456
What this trial is testing

Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies Post UCBT

Who this might be right for
Acute Graft Versus Host Disease
Anhui Provincial Hospital 134
Testing effectiveness (Phase 2)UnknownNCT04849065
What this trial is testing

Clinical Trial on the Use of Cell Therapy in the Treatment of Patients With Amyotrophic Lateral Sclerosis

Who this might be right for
ALS (Amyotrophic Lateral Sclerosis)
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia 100
Testing effectiveness (Phase 2)UnknownNCT02568241
What this trial is testing

Interferon-α After DLI for the Prevention of Relapse

Who this might be right for
Leukemia
Peking University People's Hospital 42
Testing effectiveness (Phase 2)UnknownNCT01374854
What this trial is testing

Umbilical Mesenchymal Stem Cells and Mononuclear Cells Infusion in Type 1 Diabetes Mellitus

Who this might be right for
Type 1 Diabetes Mellitus
Fuzhou General Hospital 44
Testing effectiveness (Phase 2)Study completedNCT02017457
What this trial is testing

Azacytidine and Lymphocytes in Relapse of AML or MDS After Allogeneic Stem Cell Transplantation.

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic Syndrome
Carlos Graux, MD, PhD 50
Early research (Phase 1)Study completedNCT00968760
What this trial is testing

CD19-specific T Cell Infusion in Patients With B-Lineage Lymphoid Malignancies

Who this might be right for
LymphomaB-cell Lymphoma
M.D. Anderson Cancer Center 34
Early research (Phase 1)Ended earlyNCT00469820
What this trial is testing

Vaccine Therapy With or Without Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Multiple Myeloma Undergoing Donor Stem Cell Transplant

Who this might be right for
LeukemiaMultiple Myeloma and Plasma Cell Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 1
Testing effectiveness (Phase 2)Ended earlyNCT01856582
What this trial is testing

CD34+ Stem Cell Infusion to Augment Graft Function

Who this might be right for
Waning Donor ChimerismWaning Immune FunctionPrimary Immunodeficiency Disease(s)+1 more
Children's Hospital Medical Center, Cincinnati 23
Large-scale testing (Phase 3)Not Yet RecruitingNCT06884904
What this trial is testing

Umbilical Cord-derived Mesenchymal Stem Cell Infusion for Treating ACLF

Who this might be right for
Acute-On-Chronic Liver Failure
National Engineering Center of Cell Products 96
Early research (Phase 1)UnknownNCT04097652
What this trial is testing

Mesenchymal Stem Cells for The Treatment of Acute Ischemic Stroke

Who this might be right for
Acute Ischemic Stroke
Meridigen Biotech Co., Ltd. 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT03399773
What this trial is testing

Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes

Who this might be right for
Acute Biphenotypic LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 Positive+3 more
Fred Hutchinson Cancer Center 31
Early research (Phase 1)Study completedNCT03129568
What this trial is testing

Transcoronary Infusion of Cardiac Progenitor Cells in Pediatric Dilated Cardiomyopathy

Who this might be right for
Dilated Cardiomyopathy
Okayama University 5
Testing effectiveness (Phase 2)WithdrawnNCT00004878
What this trial is testing

Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia

Who this might be right for
Graft Versus Host DiseaseLeukemia
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03265808
What this trial is testing

Allogeneic Human Mesenchymal Stem Cell Infusion vs Placebo in Alcohol Use Disorder and Major Depression.

Who this might be right for
Major Depressive DisorderAlcohol Use Disorder
Ihsan M Salloum, MD, MPH 31
Testing effectiveness (Phase 2)UnknownNCT00659620
What this trial is testing

Mesenchymal Stem Cell Transplantation in the Treatment of Chronic Allograft Nephropathy

Who this might be right for
Kidney TransplantChronic Allograft Nephropathy
Fuzhou General Hospital 20
Early research (Phase 1)Looking for participantsNCT07297173
What this trial is testing

Phase 1 Study of Chemotherapy Plus HLA-mismatched GPBMC Infusion Bridging to Allo-HSCT for R/R Leukemia

Who this might be right for
Relapsed LeukemiaRefractory Leukemia
Beijing 302 Hospital 5
Testing effectiveness (Phase 2)Study completedNCT00284986
What this trial is testing

Safety and Efficacy of Prochymal for the Salvage of Treatment-Refractory Acute GVHD Participants

Who this might be right for
Graft Versus Host Disease
Mesoblast, Inc. 11
Not applicableNo Longer AvailableNCT02051673
What this trial is testing

Induction of Donor-Specific Tolerance in Recipients of Live Donor Stem Cell Infusion (Compassionate Use)

Who this might be right for
Renal Failure
Talaris Therapeutics Inc.
Next Page